Connect with us

Hi, what are you looking for?

Right Decision NowRight Decision Now

Business

Healsgood AI raises £2.5m to scale NHS cost-saving platform Flexzo AI, bringing seed funding to £5m

Healsgood AI, the healthtech behind Flexzo AI, has secured an additional £2.5 million in seed funding from Octopus Ventures, taking total investment in its NHS workforce management platform to £5 million over the past year.

Healsgood AI, the healthtech behind Flexzo AI, has secured an additional £2.5 million in seed funding from Octopus Ventures, taking total investment in its NHS workforce management platform to £5 million over the past year.

The London-based company, which trades as Flexzo AI, is developing an artificial intelligence-driven system to help NHS Trusts and Integrated Care Boards (ICBs) cut their reliance on costly agency and bank staffing. Demand from NHS organisations has surged, prompting the fresh funding, which will support onboarding of new customers and further R&D.

This round builds on earlier backing from Fuel Ventures (£1.5m) and more than £1m from angel investors, reflecting growing confidence in Flexzo AI’s mission to modernise workforce management in the health service.

Tackling NHS staffing costs with AI

The NHS spends billions each year on temporary staff, with agency costs a persistent challenge for Trusts. Flexzo AI’s platform uses advanced AI infrastructure to enable hospitals to run their own staff banks, standardise pay rates, and optimise workforce planning.

By replacing traditional outsourcing models, Flexzo AI says its solution can deliver workforce management at a fraction of the cost, while improving transparency and conditions for frontline clinicians.

Jack Henderson, Founder and CEO of Healsgood AI, said: “The NHS has faced years of spiralling bank and agency costs. At Flexzo AI, we’re building the digital infrastructure that allows the NHS to own and manage its workforce sustainably. With Octopus Ventures, Fuel Ventures, and our angel investors behind us, we’re in a strong position to scale solutions that can save the NHS millions.”

Uthish Ranjan, Partner at Octopus Ventures, added: “Flexzo AI is addressing one of the NHS’s most urgent challenges — controlling staffing costs — with strong demand already coming from Trusts. We’re delighted to support the team as they build towards a more efficient, sustainable healthcare system.”

Shiv Patel, Partner at Fuel Ventures, said the company’s mix of “deep sector expertise and cutting-edge AI” positioned it to deliver “enormous value” to the health system.

With the NHS under financial pressure, Flexzo AI’s model aims to support both cost control and improved workforce sustainability. The company plans to expand its reach across Trusts nationwide, with longer-term ambitions to extend its technology into broader healthcare workforce and resource planning.

Read more:
Healsgood AI raises £2.5m to scale NHS cost-saving platform Flexzo AI, bringing seed funding to £5m

    You May Also Like

    Stocks

    The market sell-off continued in earnest after a brief respite on Friday. Uncertainty of geopolitical tensions and tariff talk has spooked the market and...

    World News

    BRASILIA – Brazil Prosecutor General Paulo Gonet decided not to charge former President Jair Bolsonaro with fraud in his vaccination records, asking the Supreme Court to...

    World News

    ISTANBUL — Who is Russian President Vladimir Putin sending to the peace talks with Ukraine that the Kremlin chief himself proposed Just over an...

    World News

    KANANASKIS, Alberta – Ukrainian President Volodymyr Zelenskiy leaves the Group of Seven summit on Tuesday with new aid from host Canada for its war against Russia...

    Disclaimer: rightdecisionnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 rightdecisionnow.com | All Rights Reserved